![]() |
Volumn 27, Issue 7, 2008, Pages 619-
|
Antitumour necrosis factor-alpha treatment, statins, regulatory T cells and tuberculosis
b
Ospedale di Tolmezzo
*
(Italy)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BCG VACCINE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
TRANSCRIPTION FACTOR FOXP3;
TUBERCULIN;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
BCG VACCINATION;
BLADDER CANCER;
CANCER IMMUNOTHERAPY;
CD4+ CD25+ T LYMPHOCYTE;
CYSTECTOMY;
DRUG EFFECT;
ENTERITIS;
HUMAN;
LETTER;
LYMPHOCYTE FUNCTION;
PATIENT MONITORING;
POSTPRIMARY TUBERCULOSIS;
PRIORITY JOURNAL;
REGULATORY T LYMPHOCYTE;
TH1 CELL;
TUBERCULOSIS;
TUMOR GROWTH;
DRUG INTERACTIONS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
TUBERCULOSIS;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 39849095416
PISSN: 02692813
EISSN: 13652036
Source Type: Journal
DOI: 10.1111/j.1365-2036.2008.03614.x Document Type: Letter |
Times cited : (1)
|
References (6)
|